238 results on '"Matsson, Pär"'
Search Results
2. New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium
3. Drug Metabolites Potently Inhibit Renal Organic Anion Transporters, OAT1 and OAT3
4. High Throughput Screening of a Prescription Drug Library for Inhibitors of Organic Cation Transporter 3, OCT3
5. Structural dynamics of therapeutic nucleic acids with phosphorothioate backbone modifications
6. OATPs: The SLCO Family of Organic Anion Transporting Polypeptide Transporters
7. OATs and OCTs: The SLC22 Family of Organic Anion and Cation Transporters
8. Challenges in Permeability Assessment for Oral Drug Product Development
9. Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery
10. Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation.
11. A Cell-Free Approach Based on Phospholipid Characterization for Determination of the Cell Specific Unbound Drug Fraction (fu,cell)
12. Challenges in Permeability Assessment for Oral Drug Product Development
13. The Proteome of Filter-Grown Caco-2 Cells With a Focus on Proteins Involved in Drug Disposition
14. In Vitro Characterization of Interactions with Drug Transporting Proteins
15. Computational modeling to predict the functions and impact of drug transporters
16. A Tribute to Professor Per Artursson - Scientist, Explorer, Mentor, Innovator, and Giant in Pharmaceutical Research
17. Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
18. Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs
19. Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
20. Early Identification of Clinically Relevant Drug Interactions With the Human Bile Salt Export Pump (BSEP/ABCB11)
21. In Vitro Characterization of Interactions with Drug Transporting Proteins
22. Renal Disposition of Drugs and Translation to Dosing Strategies
23. A Tribute to Professor Per Artursson - Scientist, Explorer, Mentor, Innovator, and Giant in Pharmaceutical Research
24. List of Contributors
25. Understanding polymer–lipid solid dispersions—The properties of incorporated lipids govern the crystallisation behaviour of PEG
26. Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and PBPK Modeling Approaches
27. Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches
28. Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective
29. Intracellular Drug Bioavailability : Effect of Neutral Lipids and Phospholipids
30. Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5
31. Intracellular drug bioavailability: a new predictor of system dependent drug disposition
32. Complete Knockout of Endogenous Mdr1 (Abcb1) in MDCK Cells by CRISPR-Cas9
33. Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective
34. Intracellular Drug Bioavailability: Effect of Neutral Lipids and Phospholipids
35. Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5
36. How Big Is Too Big for Cell Permeability?
37. Erratum: Structural and conformational determinants of macrocycle cell permeability
38. How Big Is Too Big for Cell Permeability?
39. Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches.
40. Structural and conformational determinants of macrocycle cell permeability
41. The Need for Speed-Kinetic Limits of Drug Transporters
42. Cell permeability beyond the rule of 5
43. Structural and conformational determinants of macrocycle cell permeability
44. Cell permeability beyond the rule of 5
45. The Need for Speed–Kinetic Limits of Drug Transporters
46. Addendum to 'Quantifying the impact of transporters on cellular drug permeability'
47. Quantifying the impact of transporters on cellular drug permeability.
48. Chapter 95 - Renal Disposition of Drugs and Translation to Dosing Strategies
49. Due Diligence - En resurskrävande process : En checklista som mindre privata aktiebolag kan följa innan de ska utföra en Due Diligence
50. Addendum to ‘Quantifying the impact of transporters on cellular drug permeability’
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.